Legal stuff probably created a bit of tension between Ian and vendors, now with vendors about to take a third of ZYL it was probably inevitable.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025